Sign in to fuzzto save your conversations, follow your research and come back anytime.
Avience Biomedicals
| Metric (₹ crore) | FY24 | FY25 | FY26 |
|---|---|---|---|
| Operating Cash Flow | 1.02 | 3.39 | 5.91 |
| Investing Cash Flow | -3.9 | -9.54 | -13.27 |
| Financing Cash Flow | 2.93 | 10.21 | 5.42 |
| Net Cash Flow | 0.05 | 4.06 | -1.94 |
| Metric (₹ crore) | FY24 | FY25 | FY26 |
|---|---|---|---|
| Equity / Shareholders' Funds | 6.23 | 22.66 | 31.41 |
| Total Liabilities | 28.41 | 33.83 | 43.16 |
| Total Assets | 34.64 | 56.49 | 74.57 |